A Glimpse Into The Expert Outlook On Danaher Through 4 Analysts

Analysts' ratings for Danaher DHR over the last quarter vary from bullish to bearish, as provided by 4 analysts.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

Analysts have set 12-month price targets for Danaher, revealing an average target of $242.5, a high estimate of $270.00, and a low estimate of $205.00. This current average reflects an increase of 3.19% from the previous average price target of $235.00.

Deciphering Analyst Ratings: An In-Depth Analysis

A clear picture of Danaher's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Danaher. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Danaher compared to the broader market.
• Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Danaher's stock. This examination reveals shifts in analysts' expectations over time.

Capture valuable insights into Danaher's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Danaher analyst ratings.

Get to Know Danaher Better

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in two segments--life sciences and diagnostics--after the late 2023 divesititure of its environmental and applied solutions group, Veralto.

Danaher: A Financial Overview

Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.

Revenue Challenges: Danaher's revenue growth over 3 months faced difficulties. As of 30 September, 2023, the company experienced a decline of approximately -10.31%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: Danaher's net margin excels beyond industry benchmarks, reaching 16.43%. This signifies efficient cost management and strong financial health.

Return on Equity (ROE): Danaher's ROE excels beyond industry benchmarks, reaching 2.17%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Danaher's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.31% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: With a below-average debt-to-equity ratio of 0.42, Danaher adopts a prudent financial strategy, indicating a balanced approach to debt management.

Analyst Ratings: What Are They?

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.

This article was generated by Benzinga's automated content engine and reviewed by an editor.